№ lp_1_2_02802
File format: docx
Character count: 2512
File size: 28 KB
This document is a template for sponsors of clinical trials to assess the suitability of a site for conducting a clinical trial, in accordance with EU Regulation 536/2014.
Year:
2023
Region / City:
EU
Subject:
Clinical Trials
Document Type:
Template
Issuing Body:
EU Clinical Trials Coordination and Advisory Group
Author:
Not specified
Target Audience:
Sponsors of clinical trials
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Dublin
Theme:
Procurement, Construction
Document Type:
Questionnaire
Organ / Institution:
Office of Government Procurement
Author:
Office of Government Procurement
Target Audience:
Tenderers, Contractors
Period of validity:
From 18 November 2024
Date of Approval:
18 November 2024
Date of Changes:
N/A
Document ID:
QW2 v2.1
Document Reference ID:
QW2 v2.1
Year:
2024
Region / City:
Utrecht
Topic:
Literary translation, machine translation, translation quality assessment
Document Type:
Thesis
Organization / Institution:
Universiteit Utrecht
Author:
Lola van Scharrenburg
Target Audience:
Academic community, translation professionals
Period of Validity:
N/A
Date of Approval:
May 2024
Date of Changes:
N/A
Year:
2021
Region / City:
United States
Topic:
Suitability determination, background checks, child protection
Document Type:
Guidance
Author:
U.S. Department of Justice
Target Audience:
Grant recipients, staff, and volunteers interacting with minors
Period of Validity:
Ongoing
Approval Date:
March 2021
Date of Modifications:
N/A
Year:
2007
Region / city:
Queensland
Theme:
Legal Profession
Document type:
Application form
Organization / institution:
Supreme Court of Queensland
Author:
Legal Practitioners Admissions Board
Target audience:
Applicants for admission to the legal profession in Queensland
Effective period:
Indefinite
Approval date:
Not specified
Modification date:
Not specified
Note:
Year
Year:
2026
Region / City:
United States
Topic:
Military readiness, medical and dental screening
Document type:
Instructional checklist
Agency / Organization:
Department of Defense
Author:
Not specified
Target audience:
Military service members
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Subject:
Environmental Protection, Solid Waste Management
Document Type:
Permit Application
Organization / Institution:
Environmental Protection Division, Solid Waste Management Program
Target Audience:
Permit Applicants, Environmental Agencies
Year:
2023
Region / City:
Massachusetts
Subject:
Long-Term Care Facility Licensing
Document Type:
Regulations
Issuing Authority:
Massachusetts Department of Public Health
Target Audience:
Applicants, owners, licensees, potential licensees of long-term care facilities
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / City:
Massachusetts
Topic:
Long-Term Care Facilities, Health Regulations
Document Type:
Public Notice
Organization:
Department of Public Health
Author:
Commonwealth of Massachusetts
Target Audience:
Public, Healthcare Providers, Stakeholders in Long-Term Care
Effective Period:
February 2026
Approval Date:
January 16, 2026
Amendment Date:
January 16, 2026
Context:
Public hearing notice regarding proposed amendments to regulations for long-term care facilities in Massachusetts.
Year:
2023
Region / city:
Netherlands
Theme:
Suitability assessment of supervisory board members
Document type:
Policy guideline
Organization:
AFM (Dutch Authority for the Financial Markets)
Author:
AFM
Target audience:
Supervisory board members, non-executive directors
Period of validity:
2023 and ongoing
Approval date:
1 April 2023
Date of changes:
1 April 2023
Year:
Not specified
Region / City:
Brussels, Belgium
Topic:
Clinical Trial Site Suitability
Document Type:
Template
Organization / Institution:
Cliniques Universitaires Saint-Luc
Author:
Jean-Louis Vanoverschelde
Target Audience:
Clinical Trial Coordinators, Researchers, Investigators
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
New Zealand
Topic:
Drug Master File, Certificate of Suitability, Pharmaceutical Documentation
Document Type:
Application Form
Organization / Institution:
Medsafe
Author:
Medsafe
Target Audience:
Active ingredient manufacturers, pharmaceutical industry professionals
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
UK
Topic:
Critical Illness Coverage
Document Type:
Product Information
Organization / Institution:
HSBC Life (UK) Limited
Author:
HSBC Life
Target Audience:
Advisers
Effective Date:
July 2023
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2024
Region / City:
Pretoria
Subject:
Court Schedules
Document Type:
Court Listing
Institution:
Gauteng Division, Pretoria
Target Audience:
Legal professionals, Court staff
Period of Validity:
20 February 2024
Approval Date:
20 February 2024
Date of Changes:
N/A
Jurisdiction:
Australia
Regulatory framework:
Therapeutic Goods Administration (TGA) Clinical Trial Notification scheme
Document type:
Regulatory notification form
Scope:
Clinical trials involving medicines, biologicals, medical and therapeutic devices
Trial phases covered:
Phase I–IV, bioavailability/bioequivalence, device studies
Subjects:
Human participants
Ethics oversight:
Human Research Ethics Committee (HREC)
Approving authority:
Relevant institutional authority
Geographic coverage:
Australian trial sites with optional international sites
Responsible party:
Lead Investigator
Fee responsibility:
Lead Investigator
Related institution:
La Trobe University
Submission requirement:
Completed form and ethics approval
Note:
Year
Subject:
Clinical Trials, Medical Research
Document Type:
Template
Organization / Institution:
EU Clinical Trials Expert Group
Target Audience:
Sponsors of clinical trials
Document type:
Instructional guidance
Subject:
Informed consent forms in clinical research
Context:
Clinical trials involving human participants
Regulatory and ethical framework:
Research ethics and regulatory compliance
Organizations referenced:
Children’s Oncology Group; National Cancer Institute; National Institutes of Health; OCREB
Funding context:
Public funding by the National Cancer Institute
Intended audience:
Consent form authors; clinical trial investigators; participating centres
Geographic scope:
North America
Population referenced:
Children and adolescents with cancer; parents or legal guardians
Related materials:
Provincial informed consent form templates; lay terminology glossary
Year:
2025
Region / city:
Ireland
Topic:
Clinical trials, Primary care, Research funding
Document type:
Request Form
Organization / institution:
Health Research Board
Author:
HRB Primary Care Clinical Trials Network
Target audience:
Lead Investigators in clinical trials
Effective period:
Until November 2026
Approval date:
N/A
Date of amendments:
N/A